Your Annual Hepatitis C Update


Hepatitis C virus (HCV) is the most common bloodborne pathogen in the United States. Baby boomers account for nearly half of chronic cases, and 75% of individuals with HCV don’t know they are infected. What can you do to address this widespread virus? Join this session to learn about new treatment options, recommended therapy and management strategies, patient education techniques to improve adherence, and opportunities to care for patients with HCV infection. 

This session is part of the Trending Topics in Ambulatory Care series and  provides a robust preparatory curriculum for the high-level pharmacy professional planning to take the BCACP examination or for those seeking BCACP recertification credit.


Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Identify important changes in recently updated guidelines that have the potential to influence the management of HCV infection.
  2. Describe clinically important drug updates, adverse effects, and drug–drug interactions associated with new drug classes used to treat HCV infection.
  3. Outline strategies for improving patient adherence to drug therapy for HCV infection and its comorbidities.
Betty Dong, PharmD
Professor of Clinical Pharmacy and Medicine
University of California School of Pharmacy
Learning Level: Level 2
Track: Ambulatory Care, Pharmacist Clinical Patient Care Services
Session Time Slot(s): 
Sunday, March 22
1:00 PM - 2:30 PM
Gaylord National - National Harbor 12-13
ACPE Pharmacist: 0202-0000-20-096-L01-P
CEUs Pharmacist: 0.15
Activity Type: